If you're in crisis right now, please reach out to a licensed professional or call or text 988 -- this is educational content, not treatment, and complex or severe trauma deserves a qualified trauma-informed therapist, not a blog post. With that said, there is real research behind several trauma approaches, and it is worth knowing what that research actually found, including the honest gaps, rather than treating every approach as equally proven just because it is popular.
The baseline: what the Cochrane review found
Cochrane reviews are the closest thing medicine has to a neutral referee, independent, methodical, and willing to say when the evidence is thin. Its review of psychological treatments for PTSD found trauma-focused cognitive behavioral therapy and EMDR were both associated with reduced PTSD symptoms compared with a waitlist or usual care, though the quality of the underlying studies varied.[1] That is a real, meaningful finding, and also a modest one. It supports these approaches as genuinely helpful for many people. It does not mean every person responds the same way, or that these are the only approaches worth considering.
EMDR: more recent evidence
Eye Movement Desensitization and Reprocessing pairs controlled exposure to a traumatic memory with bilateral stimulation, eye movements, taps, or tones. A 2024 individual-participant-data meta-analysis, a more rigorous method than pooling summary statistics, found EMDR produced PTSD symptom reduction comparable to other trauma-focused psychological therapies.[2] That is a genuinely strong, recent result. It places EMDR as one of several effective options, not as uniquely superior to the others, which is a more honest claim than either 'EMDR is a miracle' or 'EMDR is unproven.'
Somatic Experiencing: promising, and still a thin evidence base
Somatic Experiencing, developed by Peter Levine, works with body sensation rather than narrative memory, titrating exposure to traumatic activation in small amounts. The first randomized controlled trial of it for PTSD, published in 2017, assigned 63 participants to either the therapy or a waitlist and found significant improvements in PTSD symptom severity and depression in the treatment group compared with waitlist.[3] It is worth being as honest as the researchers themselves were: this is a single trial from a still-thin evidence base for an approach that is widely used in practice but has been far less studied than EMDR or trauma-focused CBT. Widely used and well-studied are not the same thing, and Somatic Experiencing is currently more the former than the latter.
Yoga and breathwork: real effects, body-based mechanism
Two more body-based approaches have real trial support. A 2017 meta-analysis of randomized trials found meditation and yoga practices associated with reductions in PTSD symptom severity, with effect sizes comparable to other established behavioral approaches.[4] A separate 2014 randomized trial found that adults with treatment-resistant PTSD who completed a 10-week trauma-informed yoga program showed greater reductions in PTSD symptom severity than those in a supportive discussion group.[5] On the breathwork side, a 2023 meta-analysis of randomized trials found structured breathwork practices associated with small to medium reductions in self-reported stress, anxiety, and depression compared with non-breathwork control conditions.[6] None of these replace treatment for complex or developmental trauma. What they share is a plausible, testable mechanism, shifting autonomic nervous system state through the body rather than only through talk, and actual randomized evidence behind them.
Reading the evidence honestly
Put together, here is the honest summary. Trauma-focused CBT and EMDR have the deepest evidence base and are reasonable first considerations for many people. Yoga and breathwork have real randomized support as adjuncts, with a body-based mechanism that makes sense alongside talk therapy rather than instead of it. Somatic Experiencing has a real, encouraging first trial and a genuinely thin evidence base beyond it, worth exploring with a qualified practitioner, not worth assuming is equally proven. None of this ranks which approach is 'best' for you specifically, because that depends on the person, the type of trauma, and what a qualified clinician sees in front of them. It is a map of what has actually been tested, so you can ask better questions of whoever you work with.
Key Takeaways
- Cochrane's review of PTSD psychological treatments found trauma-focused CBT and EMDR both reduced symptoms versus waitlist or usual care -- a real but measured finding, not a guarantee for every person.
- A 2024 meta-analysis found EMDR effects comparable to other trauma-focused therapies -- one solid option among several, not a uniquely superior one.
- Somatic Experiencing's first RCT (2017) found real benefit, but it remains a single trial for a widely-used approach -- popular and well-evidenced are not the same thing yet.
- Yoga and breathwork both have real randomized-trial support for PTSD and stress symptoms, working through the body rather than only through talk.
- This is educational, not a treatment recommendation -- complex or severe trauma deserves a qualified trauma-informed therapist, and if you're in crisis, call or text 988.
Sources
Powered by CellWell.life- 1.Bisson JI et al., Psychological treatment of post-traumatic stress disorder (PTSD), Cochrane Database of Systematic Reviews (2007)
- 2.Wright SL et al., EMDR v. other psychological therapies for PTSD: a systematic review and individual participant data meta-analysis (2024)
- 3.Brom D et al., Somatic Experiencing for Posttraumatic Stress Disorder: A Randomized Controlled Outcome Study (2017)
- 4.Gallegos AM et al., Meditation and yoga for posttraumatic stress disorder: a meta-analytic review of randomized controlled trials (2017)
- 5.van der Kolk BA et al., Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial (2014)
- 6.Fincham GW et al., Effect of breathwork on stress and mental health: a meta-analysis of randomised-controlled trials (2023)
Related